Recent Articles:

EPtalk by Dr. Jayne 5/20/21

May 20, 2021 Dr. Jayne Comments Off on EPtalk by Dr. Jayne 5/20/21

clip_image002 

Since I’m no longer providing in-person clinical care, my schedule has a different level of flexibility and I’m trying some new things both personally and professionally. Today I enjoyed attending a medical school’s Grand Rounds presentation from the comfort of my bed, which was much nicer than being in a subterranean auditorium. I’ll be doing some travel and sampling the digital nomad lifestyle a bit as well as trying my hand at Locum Tenens coverage.

For HIStalk, I’ll be adding some interviews with women leaders and entrepreneurs in health IT. I’ve already identified a couple of potential candidates but am looking for suggestions. Drop me a note with your nominee and why they would make an interesting interview. I’ll start running them in June, so stay tuned.

Lots of chatter around the virtual water cooler this week about a Kaiser Health News writeup addressing parking charges for cancer patients receiving care. The article references a research letter in JAMA Oncology last summer that looked at parking fees at National Cancer Institute-designated cancer treatment centers. Although the idea of charging cancer patients to park while they undergo treatment is particularly odious, we should be looking at the broader idea of charging patients to park, period.

I recently had care at a major institution that has billions in its endowment, but can’t afford to allow patients to park for free. Given the preponderance of organizations getting on the facility charge bandwagon as a way to increase their bottom lines, one would think that parking should be part of those facilities. As a healthcare insider, I know that many organizations run on razor thin margins, but I would argue that if you can still afford to build marble foyers with fountains and landscaping, you should take a serious look at whether charging patients to park is the right thing to do.

Kaiser Health news also ran a piece this week looking at patient reaction to having greater access to health data. Patient-side stories include patients who were anxious when seeing laboratory results without the benefit of a clinician’s explanation and those who felt offended or judged after reading physician notes. Another story mentioned a patient receiving biopsy results on the weekend, blindsiding both the patient and the physician with a cancer diagnosis. Organizations including the American Medical Association are encouraging adjustments to the rule, allowing delays for certain tests (such as biopsies) to allow physician annotation prior to release.

For some organizations, this change has not been an issue since they already provided access for more than 50 million patients. Others are creating reference guides for patients to better understand their results. My former employer is in violation, although most of the providers at the practice don’t realize that greater accessibility is now a requirement. It will be interesting to see what enforcement on this looks like.

The last water cooler conversation piece was the recent JAMA Viewpoint editorial that offered suggestions for designing successful capitated payment models for primary care physicians. I agree with the seven design elements proposed by the authors (my favorite healthcare IT crush, Farzad Mostashari, MD included). However, in order for capitated contracts to succeed, we need better support for interoperability around healthcare data in order to facilitate patient care through home health, remote monitoring, and better coordination of specialist care.

Despite what the integrated delivery networks think, there are still a good number of independent physicians out there. As a family physician, I need easy access to all the information my referral specialists hold on my patients, whether we’re part of the same network or not. Despite information blocking regulations, large health systems continue to not play nicely with anyone outside of their network and patients pay the price, not only financially through duplicated services, but medically through poor care coordination.

The Journal of the American Medical Association published a recent article that looked at whether COVID-19 vaccine registration websites were accessible to those with disabilities. The authors looked at 54 official websites in the US and compared them against the Web Content Accessibility Guidelines (WCAG) 2.0 and 2.1 guidelines. They found “suboptimal compliance” with the guidelines among the sites evaluated, with only two meeting the WCAG 2.1 standards. They call for greater availability of text-to-speech functionality to better meet user needs along with better use of color, contrast, spacing, and other presentation features to improve visual understanding.

Navigation challenges were also specifically called out in the analysis, with recommendations for improved titles, headers, labels, and links. They also recommended user testing that involves people with disabilities and ongoing evaluation as websites are updated. None of these findings are surprising to me, as I regularly have to call out technology developers for non-ideal use of color and contrast when they’re creating user-facing screens. Accessible UX design helps everyone, and I would encourage those companies that don’t have experts on staff to consider using consultants who can get the job done.

I had to break down and try to find a primary care doc recently and the whole process was only describable as a disaster. Most of the family physicians in my community aren’t accepting new patients and those that are taking new patients have a greater than six-month wait. I finally broke down and reached out to a colleague directly to see if he’d make an exception to the “no new patients” policy, which fortunately he did.

I had to play some phone tag with the office, and since this was an exception situation, the appointment line couldn’t book my appointment. Instead, they needed to me to speak directly with the physician’s medical assistant. However, they made me go through the full verbal COVID screening questionnaire before they would transfer my call, even though the appointment I was trying to book was for a month or two out. If they’re doing the verbal screening for every patient who calls regardless of what they are trying to book, it seems like a lot of wasted energy collecting screening information that will be long invalid by the time the patients arrive.

How is your institution managing COVID-19 screening in the new era of vaccines? Have things changed? Leave a comment or email me.

Email Dr. Jayne.

Comments Off on EPtalk by Dr. Jayne 5/20/21

Morning Headlines 5/20/21

May 19, 2021 Headlines Comments Off on Morning Headlines 5/20/21

Wheel Raises $50 Million Series B to Build the Next Generation of Virtual Care

White-label telemedicine and staffing startup Wheel raises $50 million in a Series B round that brings its total funding to $66 million.

Glen Tullman raises $150 million health-tech fund

Former Livongo and Allscripts executives Glen Tullman and Lee Shapiro will use $150 million in venture funding to invest in early-stage healthcare startups focused on connected consumers.

DarioHealth Acquires Digital Behavioral Health Platform WayForward

Chronic condition-focused remote patient monitoring company DarioHealth acquires WayForward for $25 million.

Comments Off on Morning Headlines 5/20/21

Morning Headlines 5/19/21

May 18, 2021 Headlines Comments Off on Morning Headlines 5/19/21

Baltimore-based digital health company to expand after securing more than $6 million in venture capital

Medication compliance and remote monitoring app developer Emocha raises $6.2 million in a funding round led by Claritas Health Ventures.

Taking a stand on vaccines at HLTH 2021

Alongside HIMSS, HLTH announces that attendees will need to present proof of COVID-19 vaccination to attend their respective events in 2021.

Scripps Health ransomware shutdown hits the two-week mark

Scripps Health in California remains offline more than two weeks after it was hit by a ransomware attack.

SymphonyRM Raises $25 Million In Series B Funding to Help Health Systems Transform Their Data Into Actionable Plans For Every Healthcare Consumer

SymphonyRM raises $25 million in a Series B funding round led by TT Capital Partners, bringing its total raised to $35 million.

Comments Off on Morning Headlines 5/19/21

News 5/19/21

May 18, 2021 News 16 Comments

Top News

image

The 2021 HIMSS and HLTH conferences will require in-person attendees to show proof that they have been fully vaccinated for COVID-19.

HLTH attendees will need to present vaccination proof via Clear’s Health Pass app, which is not yet available for COVID-19. HIMSS hasn’t decided how attendees will prove their vaccination status, but suggests that it will choose a digital solution.

Other announced items related to HIMSS21:

  • Attendees, exhibitors, and HIMSS staff who have not received the full regimen of vaccines from Pfizer-BioNTech, Moderna, J&J, or AstraZeneca will not be allowed to enter conference areas.
  • Exhibit hall booths will be spaced, as will the layout within individual booths.
  • Presenters will be required to wear face shields.
  • HIMSS has not yet decided whether attendees will be required to wear masks.
  • Seating in educational sessions will be spaced with reduced capacity guidelines, with overflow seating and live stream simulcast offered for some sessions.
  • HIMSS is still reviewing rules for networking events, but may require them to be conducted outdoors, to serve only individually portioned food and beverage items, and to employ distancing.

image

In other conference news, RSNA confirms that it will return to an in-person conference this year, starting on its usual Thanksgiving weekend at McCormick Place. RSNA  work with the convention center and the city to determine health and safety requirements.


Reader Comments

From Eadric: “Re: Meditech surgical case data. Do you know of any experts who can help point my company in the right direction to get it for our shared clients?” I don’t, but I will forward any contacts that readers suggest.

From Co-Vegas: “Re: HIMSS21. The HIMSS conference precautions won’t mean much in Las Vegas, which is anything-goes when it comes to coronavirus.” Read down the page for the just-announced HIMSS21 precautions. Las Vegas is the probably the worst US city for trying to seal off a conference to control viral spread given the mask-free intermingling of domestic and international tourists along with conference attendees in hotels, casinos, and restaurants. Convention centers are usually freestanding entities that control access to their entire footprint with their own security, but that’s not possible in Las Vegas, which intentionally makes it impossible to get from Point A to Point B without passing through crowded casinos, packed elevators, and throngs of sketchy Strip occupants.


Webinars

June 3 (Thursday) 2 ET: “Diagnosing the Cures Act – Practical Prescriptions for Your Success.” Sponsor: Secure Exchange Solutions. Presenters: William E. Golden, MD, MACP, medical director, Arkansas Medicaid; Anne Santifer, executive director, Arkansas Department of Health – Office of Health Information Technology; Kyle Meadors, principal, Chart Lux Consulting. A panel of leading experts will provide practical guidance on how to prepare for the Cures Act. Will it upend your business model? What is information blocking? How can standardized technologies be applied to meet Cures Act requirements? What must I do now as well as in the next five years?

Previous webinars are on our YouTube channel. Contact Lorre to present your own.


Acquisitions, Funding, Business, and Stock

image

Healthcare staffing, resource, and telemedicine company AMN Healthcare acquires virtual care startup Synzi from Kinderhook Industries for $42.5 million.

image

Provider management and credentialing software vendor Symplr acquires HealthcareSource, which specializes in healthcare employee recruitment, retention, and development. Symplr acquired competitor Phynd Technologies in January.

image

Employer-focused mental health tech company Lyra Health raises $200 million just four months after securing $187 million, bringing its estimated value to $4.6 billion.


Sales

  • National medical group Mednax selects R1 RCM.

People

image

Darren Dworkin (Cedars-Sinai Health System) joins Press Ganey as chief strategy officer and managing partner of PG Ventures. He has been at Cedars for 16 years as SVP/CIO, managing director of its venture organization, and executive managing director of its accelerator.

image image

Culbert Healthcare Solutions names David Francis (Steward Medical Group) SVP of management consulting services and Charlie Brown (Tower Health) VP of Epic revenue cycle consulting services.

image

Luyuan Fang (Change Healthcare) joins Prescryptive Health as chief AI and data officer.

image

Advanced Medical Strategies names David Cardelle (Change Healthcare) chief strategy officer.

image

Patient Discovery Solutions hires Theresa West (Signify Health) for the new role of chief commercial officer.

image

Dina hires Bob Maluso, MBA (Woundtech) as chief growth officer.


Announcements and Implementations

The American Medical Association announces Return on Health, which will develop a framework for assessing the value of digitally enabled care, such as telehealth.

The Minnesota Board of Pharmacy will give prescribers access to the state’s prescription monitoring program data through Appriss Health’s PMP Gateway interface.

image

Sutter Health (CA) implements Docent Health’s patient engagement technology as part of its new virtual mental healthcare program. GetWellNetwork acquired the company in January.

Blessing Health System (IL) deploys Allscripts Sunrise at Blessing Health Keokuk, Hannibal Clinic, and Scotland County Hospital. It has also signed on for the company’s managed services.

Medhost chairman and CEO Bill Anderson describes in an Amazon Web Services blog post how its multi-tenant, cloud-based EHR benefits customers and supports innovation such as machine learning, analytics, telehealth, ambient listening, mobile-friendly apps, and Alexa-based services.

image

Cleveland Clinic expands its virtual second opinion program for employers and health plans, offered with Amwell, to brain and prostate cancer.


Other

Scripps Health remains offline more than two weeks after it was hit by a ransomware attack.

image

A survey by mental health vendor Woebot Health finds that users of its therapy encounter app develop a bond — similar to that between human therapists and patients — within 3-5 days of use without diminishing over time. The “relational agent” app simulates a supportive conversation using AI and NLP that monitors and manages symptoms of stress, depression, and anxiety. I started a free trial to check it out and am not all that impressed so far – it led me through a heavily scripted “chat” that was mostly me clicking on canned responses, went through a “lesson,” insisted on a daily session (no more, no less), and then didn’t have anything useful to offer when I revisited for the second time today and said I was feeling anxious to see what would happen. Maybe it will perform better over time or as it learns.

Kaiser Health News calls out dentists who recommend unneeded or more-expensive procedures to boost their bottom lines, quoting an insurance fraud journal that concludes, “Medicaid fraud is the most lucrative business model in US dentistry today.” Corporations and private equity firms who acquire small practices sometimes order their employed dentists to push profitable procedures and fire them if they don’t. One dentist was charged with fraud after billing for $2 million in crown procedures in 18 months, which authorities say he made possible by intentionally breaking the teeth of patients with his drill while filling their cavities.


Sponsor Updates

  • Wolters Kluwer Health announces that the global customer support teams for Ovid, Lippincott, and Audio Digest have received the CRMI’s NorthFace ScoreBoard Award for the 10th consecutive year.
  • SOC Telemed will present during the virtual 2021 RBC Capital Markets Global Healthcare Conference May 18.
  • Athenahealth integrates Nuance’s Dragon Medical speech and virtual assistant technology into its AthenaOne EHR and mobile app.
  • Patient engagement vendor Sonifi Health announces a partnership with CipherHealth.
  • Capsule Technologies publishes a new white paper, “Remote Monitoring Assessment of COVID-19 Patients.”
  • Epocrates becomes the exclusive reseller of ConnectiveRx’s ScriptGuide patient savings messages.
  • Netsmart earns its seventh consecutive top post-acute technology solutions vendor ranking from Black Book Market Research.

Blog Posts


Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.

125x125_2nd_Circle

Morning Headlines 5/18/21

May 17, 2021 Headlines Comments Off on Morning Headlines 5/18/21

St. Pete telehealth company Synzi acquired for $42 million

Healthcare staffing, resource, and telemedicine company AMN Healthcare acquires Synzi, a virtual care management vendor for home health and outpatient providers, for $42.5 million.

Amazon may launch healthcare business line with at-home COVID test and other diagnostic services

Sources say Amazon may launch a home diagnostics business and a third-party marketplace for related services.

Clearlake Capital-Backed Symplr To Acquire HealthcareSource From Francisco Partners

Provider management and credentialing software vendor Symplr acquires HealthcareSource, which specializes in healthcare employee recruitment, retention, and development, for an undisclosed amount.

Mental Health Startup Lyra Health Valued at $4.6 Billion in Coatue-Led Round

Employer-focused mental health tech company Lyra Health raises $200 million just four months after securing $187 million.

Comments Off on Morning Headlines 5/18/21

Curbside Consult with Dr. Jayne 5/17/21

May 17, 2021 Dr. Jayne 2 Comments

Last week, the US Centers for Disease Control and Prevention (CDC) dropped new recommendations covering the need for mask use for individuals who have received COVID-19 vaccinations. To be honest, Thursday was overly busy and I headed out of town on Friday, so I didn’t have time to read the primary source documents before my inbox started blowing up with questions from family and friends as well as updates from businesses I frequent.

As always with the CDC, the devil is in the details, and there were footnotes to the recommendations for educational institutions. Guidance for youth summer camps and activities is still forthcoming. Unfortunately, most people just latched onto the sound bites and it was off to the races.

I spent the weekend alternating sleeping on the ground with canoeing in the rain, which was actually a lot better than it sounds. Floating through the wilderness with one of my besties is always a good time. She’s a nurse who has been run into the ground during the pandemic and definitely needed a break. Even though things are easing, her hospital is chronically understaffed and nurses are being asked to continue to give more and more when their reserves are spent. COVID-19 cases in our area are at an all-time low and her unit is no longer a pandemic overflow unit, but case mix doesn’t really matter when you don’t have enough staff to properly care for patients.

The hospital is offering bonuses for people to pick up extra shifts, but I can’t help but wonder if increasing base pay and adding additional perks would keep people from calling in sick. Creating a dedicated float pool or paying people to be on call are also options, but those cost money up front, so I guess they would rather spend it on the back end and have burned-out staff instead.

It is in this context that most healthcare providers are listening to the CDC recommendations, which were dropped on states with little notice and effectively turned small businesses and community organizations into the vaccination police overnight. The way the recommendations were released stressed the system and did not give frontline providers enough time to digest the science behind them before being hit with loads of patient questions.

Anyone with any change leadership experience knows that consensus and communication are key to effectively managing change, and both were lacking. For healthcare providers who have been exhausted caring for COVID-19 patients over the last few months, an overwhelming sentiment involved the idea that maybe we could have just waited a little bit and given clinical caregivers a break. Would it have been so bad to allow six or eight weeks so that a good chunk of the 12- to 15-year-old crowd could become fully vaccinated? Could we have had just a little more time to recharge before throwing open the floodgates nationwide? Many of us have significant concerns about potential summer spikes and the growing body of information that shows that the long-term impact of COVID-19 is going to be more significant than initially thought.

The bottom line is that very few people seem to care what healthcare providers in the trenches actually think. Frontline clinical staff have become a commodity and there’s a sentiment that we can all be easily replaced even though in reality we can’t. You can’t just replace registered nurses with patient care technicians and expect things to turn out OK. Similarly, letting your seasoned physicians walk away and replacing them less experienced (and often cheaper) resources probably isn’t the best long-term play either. The idea that happy clinicians make for happy patients seems to be lost on most medical administrators these days.

The healthcare IT industry has significant focus on patient satisfaction and patient engagement, but there aren’t a lot of tools out there for care team satisfaction or engagement. There has been plenty of conversation about the usability of EHRs for years, but it’s not just that – it’s all the different systems that we have to engage with on a daily basis.

Take scheduling systems, for example. If it is difficult and annoying for employees to schedule their shifts, does that add to their satisfaction? If the learning management system doesn’t make it easy for you to complete required training, that certainly isn’t a win, either. At my last employed position, I had to use one system to submit my schedule requests and access another system to see how my schedule actually turned out. We had three different systems for employee education – one true learning management system, one intranet site, and then random text messages distributing critical information. It made it difficult to feel like you were in command of all the information.

Our EHR was a poorly configured version of a product that I know can do better, but that had been tweaked to support our particular (or peculiar, depending on how you look at it) workflows and policies. The CPOE for in-facility medications was beyond clicky and borderline unsafe, but we were expected to just deal with it. Our PACS went down on a daily basis because it wasn’t fit for purpose given the exponential growth of the organization, but no plans were made to replace it. When concerns were surfaced, we were essentially told to just deal with it, because replacing either would be too much of a hassle “and would distract us from our patient care mission.” We were also told that they couldn’t afford to upgrade the systems, but eventually organizations reach a point where they can’t afford not to upgrade the systems. I see these same concepts played out at organizations across the US, so I know it wasn’t unique to our situation.

Knowing how burned out everyone is from the pandemic, I can’t imagine what healthcare organization employees are going through when their employer is hit by a ransomware attack. It’s hard enough to care for patients today as it is without that added stressor. We’re all suffering from compassion fatigue and have little tolerance for things that make our lives harder. Many of us are also experiencing significant moral injury from having to make ridiculous decisions that shouldn’t happen in a large, industrialized nation in the 21st century. But that’s where things have landed, and at many organizations, we are told that we should be grateful to have a job.

I’m not sure what the answer is, but I think we need a greater dialogue around how healthcare organizations care for their employees. We need more exposure to the public about what the staffing pool looks like, and the potential negative impacts on care when the caregivers are still suffering. And maybe we need some fancy new technology to put the sexy back in employee satisfaction.

Got any ideas on how to rejuvenate the healthcare workforce? Leave a comment or email me.

Email Dr. Jayne.

HIStalk Interviews John Gannon, CEO, Blue Spark Technologies

May 17, 2021 Interviews Comments Off on HIStalk Interviews John Gannon, CEO, Blue Spark Technologies

John Gannon, MBA is president and CEO of Blue Spark Technologies of Westlake, OH.

image

Tell me about yourself and the company.

I’m CEO of Blue Spark. I have been here for about 10 years. I am an aerospace engineer by training and have spent time in banking and venture capital. 

Blue Spark is a medical device company. Our primary product is TempTraq, which is a wearable, continuous temperature monitor that is designed for patients in clinical settings or remote patient monitoring environments. It’s an FDA-cleared device that is used by pharmaceutical companies and hospitals for early detection of fever.

What is the clinical value of having a patient’s temperature continuously monitored?

Temperature is the only vital sign that is not continuously monitored outside the intensive care unit phase. Temperature taking has been done globally the same way for about 150 years. It is done intermittently, taking the temperature once every four hours. In a number of disease states, patients deteriorate more quickly than within that four-hour window. That is where TempTraq plays a role, such as in oncology, where you have immunocompromised patients, or post-surgery where you are looking for infection, sepsis, or infectious disease.

The American Society of Clinical Oncology’s guideline for the US is that neutropenic fever should be treated within one hour, but they still only take their temperature once every four hours. The benefit of doing something continuously, as is done with pulse oximetry and blood pressure, is that identifying that fever early allows you to intervene sooner.

How does integration with other systems work, such as turning the stream of temperature data into something actionable?

We have designed the system to feed data into an electronic health record. EHRs are records of truth, but that is “records” as opposed to “monitoring devices.” We have a HIPAA-compliant cloud architecture called TempTraq Connect. We provide the hospital with a dashboard for real-time monitoring that can monitor either inpatients or those in remote settings, or we can push that information to their own internal systems. For example, it can go into an EHR, but we’re bringing a process live now where we are pushing data to the Vocera badging system so that nurses who are specifically aligned to rooms are getting actionable data in real time. It’s a flexible system.

What is the task management that is involved in changing a patient’s disposable patch?

Doctors we talked to at the outset of the design cycle asked for two features. The patch needs to be uniquely identifiable so you can associate a dataset with a unique ID, and then further associate that with a patient. Second is disposability. We are measuring the axillary temperature of an infectious disease patient for up to 72 hours. They don’t want to sterilize that device.

We have two versions that we sell into the hospital setting. We have a one-time use, 24-hour device and a one-time use, 72-hour device. When it’s done, you dispose of the device. The system will give you an alert 30 minutes before the end of its run time that it’s time to change that patch.

Is battery life the life-limiting factor?

Interestingly, it is not. It was a surprise in the development cycle that one of the more difficult things to get right was the adhesive. We wanted FDA clearance for all ages, which we have. We use a very gentle adhesive that is silicone gel based. That allows us to use that patch on all ages. But at the same time, we found that, particularly in adult patients wearing the 72-hour patch, the very gentle adhesive drives the end of life at 72 hours from both a hygiene and adhesive perspective. We certainly could design a patch that would run longer based on that battery, but the adhesive and hygienics were the limiting factors we found in our clinical studies.

What does the connectivity to the patch look like?

We use Bluetooth Low Energy. We are sending that signal in a hospital setting to a Bluetooth gateway that we install. It is specifically listening for TempTraq devices. That data is sent back to TempTraq Connect, our HIPAA-compliant cloud. For patients in an outpatient setting, they download our patient application to their device or use a device that is provided by the hospital or the pharmaceutical company that is running that software. Then the same thing happens to data. Once it gets Bluetooth from the patch to the phone, it is transmitted to TempTraq Connect.

Some consumer wearables, such as the Oura Ring, can measure temperature. How good is the reliability and accuracy of those devices versus TempTraq, where you had to prove your capabilities to the FDA?

The FDA is very prescriptive in terms of what is required to use a device as a clinical thermometer, which is the category we are in. FDA requires being compliant with the ASTM E1112 standard, which is plus or minus 0.1 degree Celsius within body temperature range. Beyond that, we also did clinical studies to show accuracy. We did our gold standard test at the Cleveland Clinic, where they were comparing TempTraq to readings from a pulmonary artery catheter in the chamber of the heart. The concluding statement of that study was that TempTraq was in agreement with core. Beyond what the FDA requires in terms of testing for submission, we also did human testing to show that that validation occurred on patients.

We’re seen a wide pandemic rollout of thermometer guns and walk-through fever-detecting frames that seem to offer limited accuracy and usefulness. Does that make people wary that devices like yours can actually work?

I think we’ve all had the experience of somebody using a gun and measuring our temperature at 94 degrees or something like that, hoping that it is still consistent with life. We are conscious that they have been used widely and are fairly erratic. We don’t generally run into those types of devices in the clinical setting, which is our primary market, so we don’t really view those as competitive devices. We make sure that people are familiar with the clinical studies and the standardized testing that we’ve done.

The “normal” temperature of people isn’t always the same 37 degrees Celsius. Is the change in someone’s temperature as important as its value at any given snapshot of time?

Absolutely. It has been studied over time that fever profiles across disease states have a distinctive footprint. The point that you made is a really important one, which is that 37 degrees Celsius or 98.6 degrees Fahrenheit is widely considered normal. But long, large studies have found that someone’s normal can have a standard deviation of plus or minus one degree Fahrenheit. Having a baseline and being able to look at trend data can absolutely be valuable when you are working with patients.

Is the future of the company always going to be related to temperature monitoring, or does your experience with patch technology provide more opportunities?

We view TempTraq as a platform. We have developed an unique database of continuous temperature data. Given the fact that there isn’t a lot of continuous temperature monitoring done outside of an intensive care unit, that makes that data more interesting.

We are looking at two areas of expansion. One is work that we are doing relative to being predictive around early warning. We have engaged with Adam Perer, PhD at Carnegie Mellon University to help us work on doing some of the artificial intelligence work around our network.

The other is looking at moving from univariate to multivariate, taking additional sensors and sensor readings into our database to help with that early warning score concept. But the other is looking at additional devices. We have a unique form factor in the TempTraq device. We will be looking at adding additional sensors to it, likely with a different device because the placement in the axilla under the arm, for example, is not a location that you would typically monitor another vital sign. So to do it effectively, we are probably looking a second device where we could bring in data from another vital sign.

Do you have any final thoughts?

It has been a really interesting year. If you go back 15 months, remote patient monitoring and telehealth were on the horizon, but hadn’t taken a foothold in the healthcare industry. COVID certainly has accelerated that. We have seen a breakdown of regulation to allow telehealth acceptance. We have seen a greater healthcare provider acceptance of telehealth. With that acknowledgement, there is a need to do remote patient monitoring. Not just temperature, but across all the vital signs. A lot of hospitals that we are engaged with today have initiated remote patient monitoring strategies, and we are hoping to work with them as they think through what that will look like.

There is a whole continuum of possibilities across different patient populations. We are an element of that, but it is certainly a multifaceted array of sensors that are being looked at to see what particular patient populations are most effectively tracked in the home setting. If you think about remote patient monitoring, going back a year, it really was around population health and chronic care, and now it is accelerating into the acute care setting. That is important for patients and important for overall healthcare cost. It’s an interesting time to be part of it.

Comments Off on HIStalk Interviews John Gannon, CEO, Blue Spark Technologies

Morning Headlines 5/17/21

May 16, 2021 Headlines Comments Off on Morning Headlines 5/17/21

Irish health system targeted in ‘serious’ ransomware attack

Ireland’s health service shuts down its IT systems due to ransomware, with several hospitals cancelling appointments and elective surgeries.

GoodRx to Buy Perelman’s RXSaver Business for $50 Million

Prescription savings and telemedicine company GoodRx acquires competitor RXSaver from Vericast for $50 million.

DeepScribe raises $5.2M to transcribe medical notes with AI

Automated medical transcription startup DeepScribe raises $5.2 million in a seed funding round.

Comments Off on Morning Headlines 5/17/21

Monday Morning Update 5/17/21

May 16, 2021 News 2 Comments

Top News

image

Ireland’s health service shuts down its IT systems due to ransomware, with several hospitals cancelling appointments and elective surgeries.

The government says it will not pay the demanded ransom, which some sources say is $150,000 but others report seeing locked screens that gave the amount at $20 million.

The attack involved Conti ransomware, in which attackers send an employee an email that looks like it came from a trusted colleague and contains a link to a Google Drive document that contains the payload.


Reader Comments

image

From Pipeline Fretter: “Re: ransomware. Can you ask readers what they have done lately in response to healthcare ransomware threats?” Here’s a one-question survey. Please complete and I’ll compile the results.


HIStalk Announcements and Requests

image

Brent Shafer gets a weighted average grade of C- from respondents for his time at Cerner.

New poll to your right or here: How do you expect your employer’s headcount to change between now and 12/31/21?


Webinars

June 3 (Thursday) 2 ET: “Diagnosing the Cures Act – Practical Prescriptions for Your Success.” Sponsor: Secure Exchange Solutions. Presenters: William E. Golden, MD, MACP, medical director, Arkansas Medicaid; Anne Santifer, executive director, Arkansas Department of Health – Office of Health Information Technology; Kyle Meadors, principal, Chart Lux Consulting. A panel of leading experts will provide practical guidance on how to prepare for the Cures Act. Will it upend your business model? What is information blocking? How can standardized technologies be applied to meet Cures Act requirements? What must I do now as well as in the next five years?

Previous webinars are on our YouTube channel. Contact Lorre to present your own.


Acquisitions, Funding, Business, and Stock

SOC Telemed reports Q1 results: revenue flat, with an adjusted loss of $4.6 million versus $2.7 million, beating revenue expectations but falling short on earnings. Shares in the acute care telemedicine vendor are down 26% since they began trading in November 2020 in a SPAC merger, valuing the company at $700 million.

image

Bloomberg Businessweek says that billionaire “SPAC king” Chamath Palihapitiya is raking in the cash even as the SPAC market is cooling off and investors are losing big chunks of money. The article describes his involvement with Clover Health, a small, money-losing insurance company that tries to dazzle investors with its technology:

  • Unlike traditional IPOs, SPAC companies can make whatever wild business projections they want.
  • The SPAC’s sponsor keeps 20% of shares as their fee.
  • Palihapitiya uses his huge social media following to hype his SPACs. He and his partners doubled their money, much of it borrowed, to $320 million as Clover Health’s investors watched their shares drop in value.
  • Clover wasn’t a startup. It had been flailing along on technology hype since 2012, but has burned through hundreds of millions of investor dollars while missing growth targets and replacing executives.
  • Clover Health’s plans are rated in the bottom 15% of the government’s star rating system.
  • The company’s efforts to expand outside of New Jersey have not been successful and it still sells only Medicare Advantage plans, but it has changed its story to position itself as a software business because of its Clover Assistant physician advice software.
  • The reporter contacted four doctors who the company had recognized as being dedicated Clover Assistant users, of which only one confirmed that he had actually used it and even then that doctor said it wasn’t useful. The company claims that they have analytics showing regular use even though doctors may not recognize the product name.
  • The company did not disclose Department of Justice inquiries about its sales practices or that its co-founder ran a hospital chain that had been accused of price gouging.
  • CLOV shares are down 50% since their first day of trading in early January, the same average percentage loss as all of Palihapitiya’s SPACs.

Sales

  • University of Vermont Health Network will deploy Visage Imaging’ s enterprise imaging platform via a public cloud.

COVID-19

CDC reports that 56% of eligible Americans have received at least one dose of COVID-19 vaccine and 44% are fully vaccinated. An astonishing 158 million people have been given at least one shot.

image

Here’s what a vaccine can accomplish in four months.

Experts say the eight-player COVID-19 outbreak among the New York Yankees is evidence that the vaccine works since seven of them had no symptoms and nobody got sick. They remind the public that while vaccines aren’t quite 100% protective against infection, they are nearly 100% effective against hospitalization and death. The article notes that most or all of the players would likely not have known they were infected except for the regular testing that pro sports requires.


Sponsor Updates

  • Clinical Architecture will present during the virtual AMIA Clinical Informatics Conference May 18.
  • OptimizeRx will present at the RBC Capital Markets Global Virtual Healthcare Conference May 19.
  • PatientPing releases a new e-book, “CMS’ E-Notifications CoP: The Route to Compliance – Part 3.”
  • Relatient publishes a case study, “The Power of a Platform: How This Medical Group Improved Patient Satisfaction, Reduced No-Shows and Increased Revenue with a Comprehensive Patient Messaging Strategy.”
  • Premier will host a tweet chat (#PremierChat) with President and CEO Michael Alkire May 19 at 6pm ET.
  • Providence Ventures’ Funding the Future of Healthcare Podcast features Protenus CEO Nick Culbertson.
  • Pure Storage recognizes six customers driving innovation in its inaugural Breakthrough Awards program.
  • RCxRules publishes “Best Practices Guide to HCC Coding: 9 Ways Top-Performing Organizations Improve RAF Scores.”
  • CRN includes Spirion Senior Director of Business Development Melissa Murillo on its “Women of the Channel” list for 2021.
  • AI Tech Park interviews Wolters Kluwers Health VP & GM Frank Jackson.

Blog Posts


Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.

125x125_2nd_Circle

Weekender 5/14/21

May 14, 2021 Weekender Comments Off on Weekender 5/14/21

weekender 


Weekly News Recap

  • Patient payments platform vendor Cedar announces that it will acquire competitor OODA Health for $425 million.
  • ONC will spend $80 million of American Rescue Plan funds to train public health professionals to modernize the public health data infrastructure.
  • “Hospital at home” and decentralized clinical trials platform vendor Huma raises $130 million.
  • Mayo Clinic and Kaiser Permanente make a rumored $100 million investment in Medically Home.
  • Regulators in England block Imprivata’s planned acquisition of digital identity vendor Isosec.
  • Amwell’s Q1 results send shares down sharply as investors fear a growth slowdown.
  • CPSI acquires TruCode.
  • Aetion, which offers a real-world evidence platform for drug companies and payers, raises $110 million.
  • “Hospital-at-home” company Huma raises $130 million.
  • Walmart Health acquires telehealth provider MeMD.
  • Health Catalyst’s Q1 results beat expectations.

Best Reader Comments

So what should Cerner do, though? They have some market issues because the largest potential or current customers have attached medical groups and those medical groups drive customers to Epic. The customers that don’t fit that description are substantially more price sensitive. With their current product and a replacement market, they need to have significantly lower costs to win deals. Their strategy now seems to be slowly cut costs and lose customers until they are a government contracting company. They should have kept going on the RCM, support, data sales, analytics on the theory that the EHR is sold closer to at cost and they make it up on services. Make a couple acquisitions (Athena) and they could have a strong alternative to play against Epic’s weaknesses. That would have required looking further ahead than the next couple quarters. (IANAL)

That’s been our experience as well at Parkland and broadly with Dallas County, TX public health department. Specifically related to COVID-19, we were strategically able to utilize ML derived insights to improve many aspects of COVID-19 related workflows including patient triage, testing site optimization, identification of COVID-19 hot spots, and vaccination prioritization and understanding of herd immunity to just name a few. And we continue to build on it to help with other public health issues such as access & equity, other communicable diseases etc. AI/ML is a useful tool and is constantly getting better and when aligned with strategic goals and with the right moral compass can be really useful. (Vikas Chowdhry)


Watercooler Talk Tidbits

image

Readers funded the Donors Choose teacher grant request of Ms. J in North Carolina, who asked for a library of books for her middle school agricultural education students. She reports, “My students have learned so much about Theodore Roosevelt, Milton Hershey, and Temple Grandin this semester. It has tied in with our current curriculum related to natural resources (Roosevelt), food science (Hershey), and animal science (Grandin). Students were able to listen and watch recordings of me reading the book (to assist students with reading challenges) in order to gain more understanding about the individuals and the industries they impacted. We were able to have meaningful discussions about each book. This was an eye-opening experience for some of these students.”

I don’t actively solicit Donors Choose donations since you can donate to them directly without my involvement, but if you want to donate and have matching funds applied from my Anonymous Vendor Executive, do this:

  • Purchase a gift card in the amount you’d like to donate.
  • Send the gift card by the email option to mr_histalk@histalk.com (that’s my DonorsChoose account).
  • I’ll be notified of your donation and you can print your own receipt for tax purposes.

image

Former Collective Medical executive Kat McDavitt, along with the Sharp Index, has started Mothers in Medicine, a fund that provides frontline healthcare workers who are struggling to pay for childcare with grants of $1,000 per child. She welcomes donations, volunteer help, and stories from clinician mothers.

image

A former Indiana sinus surgeon who hid out in the Italian Alps for three years to dodge healthcare fraud charges but was eventually arrested and sentenced to seven years in federal prison turns up in Florida after his release after five years, where he is trading in cryptocurrency and selling yoga classes so customers can get “hot chicks” and “look great naked.” His license was permanently revoked in 2005 and 300 of his patients shared in a $55 million medical malpractice settlement. He vanished from a yacht in the Greek Islands in 2004, abandoning his family and leaving them $6 million in debt to hide out in a tent in the mountains, where he was later turned in by his Italian girlfriend after he was featured on “America’s Most Wanted.” His practice had been profitable – he commuted from Chicago to the working class suburbs of Indiana via chauffer-driven limousine, sent a different chauffeur back to Chicago at lunchtime to bring him his favorite sushi, lived in a five-story townhouse worth $3 million, and owned the 80-foot yacht from which he intentionally vanished.

image

Employees of Swedish Medical Center (CO) throw a prom for 18-year-old Miracle Manzanares, who missed her own event while being hospitalized for 10 weeks with serious burns. She will be discharged soon.


In Case You Missed It


Get Involved


125x125_2nd_Circle

Comments Off on Weekender 5/14/21

Morning Headlines 5/14/21

May 13, 2021 Headlines Comments Off on Morning Headlines 5/14/21

Cedar Announces Agreement to Acquire OODA Health to Revolutionize the Consumer Financial Experience in Healthcare

Patient payments platform vendor Cedar will acquire competitor OODA Health for $425 million.

Boston-based tech company raises $8M to develop AI-powered CVD software

Elucid, a developer of cardiovascular diagnostic image analysis software, raises $8 million in a Series A funding round.

Biden-Harris Administration to Invest $7 Billion from American Rescue Plan to Hire and Train Public Health Workers in Response to COVID-19

ONC will spend $80 million to train public health professionals to modernize the public health data infrastructure.

Mayo Clinic, Kaiser Permanente announce strategic investment in Medically Home to expand access to serious or complex care at home

Mayo Clinic and Kaiser Permanente make an unspecified investment in Medically Home, which offers technology and services to support delivering acute care and recovery services at home.

Jasper Health Launches Comprehensive Support Platform for Individuals With Cancer and Their Caregivers

Digital cancer care organization platform vendor Jasper Health launches with $7 million in seed funding, naming as its top executives two veteran leaders of CVS Health and Walgreens.

Comments Off on Morning Headlines 5/14/21

News 5/14/21

May 13, 2021 News 4 Comments

Top News

image

Patient payments platform vendor Cedar will acquire competitor OODA Health for $425 million.

OODA’s co-founder, chairman, and co-CEO is Giovanni Colella, MD, who also co-founded Castlight Health and founded RelayHealth.

Colella founded OODA with two other former Castlight executives in 2017.


Reader Comments

image

From Notinda House: “Re: Salesforce. Sad to see them let go another leader of their healthcare vertical, Ashwini Zenooz. Like a few of her predecessors, she was only there two years. Not sure her VA experience is a good fit for a sales focused organization. Do you think SF has a hiring problem in that they hire the wrong leader consistently? Or maybe they do a good job because they are consistent?” The LinkedIn of radiologist Ash Zenooz, MD says she left her Salesforce job as chief medical officer / GM in April and is now president and chief medical officer of Commure.

From Gladhander: “Re: HIMSS21. Predictions on attendance? Time to run another poll about who’s going?” No and no. All I can say is that I’ll be there to recap whatever happens. I won’t have a booth, but I’ll do my usual guide to what HIStalk sponsors will be doing there, cover everything I hear in the exhibit hall and hallways, run photos of what it looks like, and share any big announcements (if indeed companies are holding any back for the conference’s first day). As I wrote the other day, unlike previous years, many registrants are just carrying over their use-it-or-lose-it HIMSS20 registration, plus hotels can be cancelled up until right before the conference starts with minimal penalty (zero if by July 12, one night’s stay after that), so no amount of data will predict who will actually show up. The good news is that COVID-19, as it relates to both infection risk and hospital workload, should not be a factor. I don’t have any sage wisdom for companies that are trying to decide whether paying full price to participate in a potentially scaled-back conference is worth it, although perhaps the potential competitive penalty for sitting out is light since the full, normal HIMSS22 will be just six months later.


HIStalk Announcements and Requests

Reader Lloyd’s generous donation, with matching funds applied from my Anonymous Vendor Executive and other sources, fully funded these Donors Choose teacher requests:

  • A document camera for Ms. C’s sixth grade class in Provo, UT.
  • Science kits for Mr. C’s elementary school class in Westminster, CA.
  • Science mystery kits for Ms. L’s eight grade class in El Paso, TX.

Listening: Who bass player John Entwistle, in this remarkable video that isolates his work on “Won’t Get Fooled Again” in a live performance. He looks entirely bored while flawlessly and apparently effortlessly playing the most complex and musically rich bass lines imaginable, surely later inspiring Rush’s Geddy Lee to forget just laying down root notes and instead rip it like a lead guitarist. The song is simple and I would not have suspected that so much bass artistry was happening underneath, especially since I don’t particularly like the song. He died in 2002 at 57.


Webinars

June 3 (Thursday) 2 ET: “Diagnosing the Cures Act – Practical Prescriptions for Your Success.” Sponsor: Secure Exchange Solutions. Presenters: William E. Golden, MD, MACP, medical director, Arkansas Medicaid; Anne Santifer, executive director, Arkansas Department of Health – Office of Health Information Technology; Kyle Meadors, principal, Chart Lux Consulting. A panel of leading experts will provide practical guidance on how to prepare for the Cures Act. Will it upend your business model? What is information blocking? How can standardized technologies be applied to meet Cures Act requirements? What must I do now as well as in the next five years?

Previous webinars are on our YouTube channel. Contact Lorre to present your own.


Acquisitions, Funding, Business, and Stock

image

“Hospital at home” and decentralized clinical trials platform vendor Huma raises $130 million in a Series C funding round, increasing its total to $200 million. The London-based company, which changed its name from Medopad a year ago, will use the money to expand its platform to the US, Asia, and Middle East.

image

Mayo Clinic and Kaiser Permanente make an unspecified investment in Medically Home, which offers technology and services to support delivering acute care and recovery services at home. The company had previously raised $65 million.

Regulators in England block Imprivata’s planned acquisition of Manchester-based digital identity vendor Isosec, which has 120 NHS customers. The Competitions and Markets Authority said that the companies are rivals in the digital identity verification business and removal of a competitive threat to Imprivata would negatively impact taxpayer value.

image

New York City-based digital cancer care organization platform vendor Jasper Health launches with $7 million in seed funding, naming as its top executives two veteran leaders of CVS Health and Walgreens.

image

Amwell reports Q1 results: revenue up 7%, EPS –$0.16 versus –$0.58, beating earnings estimates but falling short on revenue. Shares dropped nearly 25% Thursday following the report and have shed nearly 60% of their value in the past 12 months, valuing the company at $2.4 billion.

DrFirst closes a $50 million equity investment that increases its total raised to $118 million.

CPSI acquires encoder solutions provider TruCode.


Sales

  • Penn Highlands Healthcare (PA) selects Infor CloudSuite Healthcare and Cloverleaf Cloud.

Announcements and Implementations

In the UK, Cognetivity will use InterSystems IRIS for Health to integrate its IPad-based early detection questionnaire for early dementia detection, which it Cognetivity says can identify the condition up to 15 years earlier than conventional methods.

image

A new KLAS report on revenue cycle outsourcing finds that the mostly mid-sized clients of Ensemble Health Partners are highly satisfied, while R1’s clients tend to be larger and are happy with the company’s direction and technology. Those companies top the “most likely to buy again” list. More than 80% of NThrive’s clients are dissatisfied and the company trails competitors in every segment in which the company is rated by KLAS, while 43% of Conifer Health Solutions clients report dissatisfaction because they say the company is not proactive or innovative.


Government and Politics

ONC will spend $80 million to train public health professionals to modernize the public health data infrastructure, part of the White House’s $7.4 billion in spending under the American Rescue Plan to expand the public health workforce.

image

ONC invites submissions for outcome statements related to its Health Interoperability Outcomes 2030 project.


COVID-19

image

New CDC guidance says that fully vaccinated Americans don’t need to wear masks or distance from others under any circumstances, including while indoors or outdoors and in gatherings of any size, except where local regulations or a business’s rule require it or when using public transportation. CDC Director Rochelle Walensky, MD, MPH announced, “If you are fully vaccinated, you can start doing the things that you had stopped doing because of the pandemic. We have all longed for this moment when we can get back to some sense of normalcy.”

The seven-day rolling average of US COVID-19 deaths was at 629 Wednesday, the lowest since last July. That’s down more than 80% since the peak in mid-January. US deaths are at 580,000.


Other

A security researcher discovers an unprotected online database that contained the records of 200,000 patients of a national disability evaluation services company based in Jacksonville, NC. United Valor Solutions responded quickly to have its (unnamed) contractors shut down public access, although the researcher also found ransomware-related files on the server.

image image

Ocean City, MD first responders celebrate the heroism of Atlantic General Hospital (MD) CIO Jonathan Bauer, who saw that a two-year-old girl had been ejected – still in her car seat — into the Assawoman Bay during a five-car crash. He dove off the bridge, which was 30 feet above water that is five feet deep, and kept the girl’s head above water until both were rescued by boat. He asked to remain anonymous, but the city wanted to recognize him. The toddler is fine.

jf

Forbes is right – I have never heard of Judy “Falkner.” The accompanying video is as lame as the headline writer’s spelling skills (also botched was writing “women” instead of “woman”).  Was there a time when Forbes had credibility?


Sponsor Updates

  • EClinicalWorks posts a new episode of its podcast titled “How Software Updates Promote Usability and Patient Safety.”
  • Critical event management company Everbridge completes its acquisition of XMatters to accelerate digital transformation for enterprise IT and cyber resilience.
  • Healthwise partners with the City of Boise, Idaho to develop and open the Hillside to Hollow Reserve and trailhead.
  • Optimum Healthcare IT publishes a white paper titled “Governance: What’s the Big Deal?”
  • Fast Company recognizes Jvion’s COVID Community Vulnerability Map with an honorable mention in its 2021 World Changing Ideas Awards.
  • St. Luke’s Health System uses Meditech’s self-scheduling for COVID-19 vaccination.

Blog Posts


Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.

125x125_2nd_Circle

EPtalk by Dr. Jayne 5/13/21

May 13, 2021 Dr. Jayne Comments Off on EPtalk by Dr. Jayne 5/13/21

Not surprisingly, the big news around the virtual water cooler this week was the approval of the Pfizer COVID-19 vaccine for the 12- to 15-year-old age group. In my community, most of the health system vaccination sites began to schedule vaccination appointments for that group for Thursday and Friday in advance of the expected approval. Only the retail clinics held the line, and my guess is they were frantically updating websites Wednesday evening. Colleagues in several other states reported that vaccination sites weren’t waiting for the final CDC approval but took the FDA emergency use authorization as enough to go ahead and start vaccinating younger teens on Tuesday. It will be interesting to see what happens to vaccine rates now, with many parents wanting their children vaccinated so they can get “back to normal.”

Another boost to vaccination rates, particularly among young healthy men, might be this article that explores concerns about COVID-19 causing erectile dysfunction. Researchers at the University of Miami Miller School of Medicine found detectable viral RNA in the penile cells of COVID-19 positive patients at a substantial interval after the initial infection. They conclude that the same kinds of cellular dysfunction caused elsewhere by COVID-19 infections may be contributing to erectile dysfunction. I’ve been saying for a while now that this is a weird virus and we’re a long way from understanding exactly what it can do. I suspect this isn’t the last of the unusual complications that we’ll learn of.

Another journal article that crossed my desk this week should be near and dear to many healthcare IT professionals. Molecular Psychiatry published a piece describing how “Habitual coffee drinkers display a distinct pattern of brain functional connectivity.” Researchers used functional magnetic resonance imaging (fMRI) to assess brain changes. The findings support an association between coffee consumption, improved motor control, cognitive focus, and alertness. Similar changes could also be seen in the brains of non-coffee drinkers after consuming even a small amount of coffee. I’m not a huge coffee drinker, but do like an iced coffee from time to time, although too much tends to make my hands shake, which is not good when you have to sew people up for a living. Maybe I’ll be able to enjoy it more often now that I’m no longer in the urgent care trenches.

We’ve certainly moved into a new phase of the pandemic, and that’s the one where drug companies begin direct-to-consumer advertising for COVID-19 related treatments. Regeneron has started its advertising campaign for monoclonal antibodies. The advertisements are permissible under the FDA’s emergency use authorization, and four commercials have been developed. As with nearly every other drug ad, patients are told to “ask your doctor” about the treatment. We screened people for potential treatment at my former employer, and the reality was that very few patients qualified and even fewer actually wanted to go to the infusion center for a treatment. It will be interesting to see if the ads actually drive business.

clip_image001

The HIMSS21 schedule for in-person general education sessions is now live. I went ahead and dropped the keynotes, exhibit hall times, and registration info on my calendar, but it’s hard to get excited about choosing sessions just yet. Many of my healthcare IT colleagues are still debating whether they’re going or not, wondering if the expense will be worth it, especially if they have to pay out of pocket. My local university is still on a travel ban as are several of my favorite vendors, so right now very few of my besties are planning to attend. Those of us going will make the most of it, though, and it will certainly be good to see people in person.

clip_image003

Sometimes I run across products that are solutions in search of a problem, and I’m fairly certain the Q-Pad by vendor Qvin fits this description. The device is a menstrual pad with an embedded test strip used for laboratory-based hemoglobin A1c testing. The company differentiates itself based on needle-free blood testing without regard for the fact that patients who are in need of hemoglobin A1c testing also need a variety of blood tests that aren’t available on their platform. Like any good device vendor, the company provides a smartphone app. Direct-to-consumer pricing is available on a one-time, monthly, or quarterly basis despite the lack of evidence for random testing in the menstrual-age population. The website contains a video interview with the founder, who says the device appeals to the “quantified self” crowd.

clip_image005

I’m a big fan of the Honor Flight Network and had the privilege of traveling on a flight with my favorite Korean War veteran. It’s an amazing experience that was curtailed by the COVID-19 pandemic, with only one flight going in 2020 before everything shut down. I was glad to see an outstanding application for virtual reality technology to help continuing honoring veterans, as T-Mobile partnered with Healium and the Honor Flight Network to virtually transport veterans to see their memorials in Washington, DC. Honor Flight is gearing up to restore the trips as soon as it is safe and practical, but the reality is that we will lose many of our WWII veterans before they can travel, and many more are not physically able to make the trip. Kudos to these organizations for their support of our veterans.

clip_image007

Marketing folks of the world – I highly recommend testing your email blast software on a small distribution list before just cutting it loose. Clearly the email I got didn’t format as intended, and since it’s supposed to be coming from a communications specialist, it doesn’t inspire confidence.

For fans of “The Six Million Dollar Man,” the time for “bionic” eyes has arrived. Researchers at the Keck School of Medicine at the University of Southern California have created the Argus II to provide limited vision to blind individuals. Although it’s currently limited to helping people recognize shapes and patterns, they hope to eventually provide the ability to see colors and details.

What’s your favorite technology from vintage TV that has become a reality, or that you can’t wait to see some day? Leave a comment or email me.

Email Dr. Jayne.

Comments Off on EPtalk by Dr. Jayne 5/13/21

Morning Headlines 5/13/21

May 12, 2021 Headlines Comments Off on Morning Headlines 5/13/21

$50 Million Follow-on Equity Investment from Sixth Street Growth Caps $135 Million Total in 2020-21 for DrFirst

Health IT company DrFirst announces a $50 million equity investment from Sixth Street Partners, bringing its total raised over the last 12 months to $135 million.

Ettain group, a Leading Provider of Talent Solutions, Acquires Bradford & Galt, an IT Staffing and Consulting Firm

Ettain Group acquires Bradford & Galt, a staffing and consulting firm specializing in EHR go-live support and training.

CPSI Announces the Acquisition of Medical Encoder Solutions Provider, TruCode LLC

CPSI, parent company of TruBridge, Get Real Health, Evident, and American HealthTech, acquires coding and revenue cycle optimization company TruCode.

Comments Off on Morning Headlines 5/13/21

Readers Write: AI is Essential to Stopping Further COVID-19 Spread and Limiting Future Pandemics — Here’s Why

May 12, 2021 Readers Write 3 Comments

AI is Essential to Stopping Further COVID-19 Spread and Limiting Future Pandemics — Here’s Why
By Sally Embrey

Sally Embrey, MSPH, MS is VP of public health and health technologies of DataRobot of Boston, MA.

image

It is safe to say that 2020 showed us the limitations of the US healthcare structure and a long-antiquated approach to public health and emergency preparedness. Under lockdown, it became clear how unequipped the world was to address the scope of the COVID-19 pandemic. Since the onset of the greatest healthcare crisis in our lifetimes, the strengths and weaknesses of our healthcare system came into clear focus, while the consequences of our failures will be felt for years to come.

But how do we move forward? In the United States, COVID-19 spread has varied widely, from states to cities and counties. This spring, as COVID-19 cases in Michigan, New York, and New Jersey were slowly declining, cases in Oregon were increasing at higher rates than anywhere else in the United States, according to The New York Times.

One thing that has been emphasized time and time again is that the absence of more complete, accurate, and representative data was a key and often missing factor in our ability to effectively respond to the COVID-19 pandemic. We also learned that the systems required to process that data were as equally important to delivering the insights needed. The pandemic has made the role of AI in the healthcare field essential to preventing and mitigating future pandemics.

Research groups worldwide built and deployed various AI-driven systems that sought to fight the pandemic. For example, researchers developed systems that automatically analyzed CT images to provide the probability of COVID-19 infection to rapidly detect COVID-19-related pneumonia. Since AI can locate lesions in seconds instead of hours, it can significantly reduce the workload for already overburdened physicians. Other models were developed and deployed throughout COVID-19 to help understand clinical severity and identify the patients most at risk of serious illness and even death. By deploying AI, healthcare systems could prioritize which patients needed to be hospitalized and provided immediate care, and early care was shown numerous times to help with health outcomes.

At the same time, AI systems gave the federal government and state governments insight into where resources were needed most critically. They utilized AI-driven long-term forecasting models to understand the scope and spread of COVID-19, as well as drive site selection during the vaccine trials by predicting where outbreaks were most likely to occur up to eight weeks before cases increased. This could forever change how we enroll individuals into clinical trials, which are typically constrained to research hospitals or highly manual processes. Improving and streamlining the approval of vaccinations is the golden ticket to infectious disease prevention.

Organizations across the healthcare and technology industries also stepped outside of the box to create at-home COVID-19 antigen tests, many of which have an accompanying gamified platform. By combining physical antigen tests with AI and an accessible digital platform, patients are better able to understand their risk of being contagious with COVID-19. Arming people with information about their COVID-19 risk through innovative solutions powered by AI is the solution for slowing and preventing future pandemics.

As a leading nation in health research and technology, we have a responsibility to do better, and we must ensure we can more quickly contain this type of outbreak in the future. By leveraging the importance of complete, accurate, and representative data and combining it with the power of AI and public-private coordination, we can and will be ready to stop future pandemics.

Readers Write: Providers’ Post-Pandemic Assessments of Telemedicine

May 12, 2021 Readers Write Comments Off on Readers Write: Providers’ Post-Pandemic Assessments of Telemedicine

Providers’ Post-Pandemic Assessments of Telemedicine
By Amanda Hansen

Amanda Hansen is president of AdvancedMD of South Jordan, UT.

image

Healthcare delivery has shifted dramatically since March 2020, when the COVID-19 pandemic hit. For many providers, telemedicine had fallen into the category of a “someday, maybe” service, not a practice essential that was regularly requested or required of them. But when social distancing mandates were enacted to reduce the potential for infectious exposures, demand and the subsequent adoption of telehealth skyrocketed.

About 90% of providers say they are conducting some of their patient visits via telehealth. They have rapidly scaled offerings to see 50 to 175 times the number of patients via telehealth than they did before the pandemic. Going forward, it is projected that virtual visits will account for $250 billion, or 20%, of what Medicare, Medicaid, and commercial insurers spend on outpatient, office and home health visits.

Given the rapid and event-specific changes to telemedicine’s applications, we were curious about the impact to independent practices and their impressions that will come to shape the future of remote clinical services. Are practices capitalizing on the promise that telemedicine saves them both time and money? What has the effect been on the patient experience? We were interested specifically in the following aspects of telemedicine provision:

  • Effect on time spent with patients.
  • Effectiveness in reducing barriers.
  • Impact of care costs.
  • Impact on quality of care

In early April. we partnered with nearly 200 select physician offices to conduct a survey addressing these very questions.

Access

An overwhelming majority of survey respondents, 75%, find that telemedicine reduces or eliminates barriers to care for their patients. For practices, this access is expanded without increasing staff or marketing costs.

The ability to provide effective care is a largely a function of provider availability and visit timing. In many segments of healthcare — such as mental health, primary care, and various specialties — the shortage of providers results in excessive wait times for appointments. Telemedicine makes providers more available and creates opportunities for additional visits, reducing barriers to care.

Convenience

Telemedicine enables flexibility for patients, streamlining care for those outside the immediate area. It also enables quicker resolution for diagnoses and prescribing. Practices offering telemedicine visits are able to divert patients from more costly and complex care settings like emergency rooms. Chronic care patients, in particular, are much more likely to visit with a care provider before the condition enters a crisis and maintain standard care continuity when it is seamless and simple. Convenience remains integral to reducing both barriers and cost of care.

Quality

Among survey respondents, 38% say they are providing more quality care using telemedicine. In one of our other recent surveys, 59% of providers said they feel they are able to provide higher quality care with telemedicine. In the early months of the pandemic, telemedicine allowed practices to remain open to provide the quality services their patients required. Today, the service allows practices to maintain and grow their patient volumes.

Engagement

Telemedicine enables 24% of responding providers to spend more time with patients, but engagement goes beyond time per appointment. Practices that integrate telemedicine with the EHR and other practice management tools like portals, scheduling, text alerts, and claims processing serve patients who are more engaged in their own care. Solutions that meet patients where they are make care management functions seamless and simple. With telemedicine as part of the engagement strategy, patients are getting the same healthcare experience online that they have in traditional, onsite visits, and can even shop for doctors who provide the service and have availability at set times. Engaged patients are healthier patients.

For providers, telemedicine is serving a new purpose. With 271 telehealth case types (with CPT codes) reimbursable by CMS, there are many opportunities to expand utilization and revenue streams. In the decade prior, physicians often engaged in patient phone or video calls without any reimbursement whatsoever. Now, providers are able to deliver services to those who need it with a technology that has proven effective and advantageous.

By reducing costs and breaking down barriers, telemedicine is improving the quality and efficiency of care delivery.

Comments Off on Readers Write: Providers’ Post-Pandemic Assessments of Telemedicine

Readers Write: Sharing Diverse Patient Data to Support Clinical Trials: Can We Afford Not To?

May 12, 2021 Readers Write Comments Off on Readers Write: Sharing Diverse Patient Data to Support Clinical Trials: Can We Afford Not To?

Sharing Diverse Patient Data to Support Clinical Trials: Can We Afford Not To?
By Monica Matta

Monica Matta is head of operations and GM of provider business at COTA of Boston, MA.

image

Flatly,  we cannot.

Clinical trials are the foundation of innovation in the fight against hard-to-treat diseases, including cancers. For the millions of people living with cancer, and the millions more who will be newly diagnosed this year, clinical trials are critically important for opening up new treatment options and paving the way for improved outcomes.

Cancer may affect everyone, but not everyone has equal access to the resources and research projects designed to combat this complex group of diseases. Certain racial and ethnic groups are systematically excluded and chronically disenfranchised when it comes to screening, testing, and clinical care.  These groups, including individuals affected by the socioeconomic and environmental determinants of health, often experience worse health outcomes and mortality at higher rates.

Black patients, for example, are significantly more likely than members of any other group to die from many cancers, including prostate cancer, breast cancer, and multiple myeloma. While black patients account for anywhere from 15-20% of the national incidence of these diseases, they only comprise 3-5% of clinical trial representation. This is a huge problem.

Clinical trials for new therapies are often not truly representative of the populations the therapies will be treating. Lower participation rates not only leave patients without access to potentially ground-breaking therapies, but also leave investigators with worrisome gaps in knowledge about the efficacy and safety of these treatments in the wider, real-world population.

The ethics are clear. There are also financial arguments supporting the need for increased diversity in clinical trials. If manufacturers and payers cannot verify that new therapies are going to achieve the desired result across all potential populations, why should they invest time and resources in distributing these agents to patients?

We simply cannot afford, both morally and more tangibly, not to focus on architecting more representative and inclusive clinical trials.

We can begin to meet the needs of underserved and underrepresented populations by encouraging more individuals to participate in clinical trials and prioritizing the evaluation of real-world outcomes with an emphasis on privacy and ensuring equitable access to the results. In order to do so, investigators must have access to rich, curated, diverse real-world data that accurately capture the experience and outcome of patients from all backgrounds.

Healthcare providers, including cancer centers, oncologists, and other specialists, remain a critical conduit for facilitating education about the benefits of data sharing and connecting patients with clinical trial opportunities. We must continue to build strong relationships between patients, providers, and clinical trial sponsors to gain the trust and input of diverse populations.

As we look to the future, however, there is much potential in leveraging technology and portals to clinical research marketplaces that allow individuals to grant access to their personal data assets for specific, well-defined use cases. These marketplaces will likely include some type of data dividends as compensation for participation. Patients can then become the direct purveyors and benefactors of their data, creating an entirely new model which reengages the right stakeholders in the conversation once more.

As we develop these ideas and tackle the myriad issues around the creation of such a system, we will need to keep informed, empowered patients at the center of all we do. Privacy, security, and equity must remain paramount to ensure our efforts are transparent, sustainable, and effective.

Whatever the next generation of data sharing will look like, we have opportunities right now to meet our obligations to patients. By pairing technical innovations with clinical expertise, we can lay the foundations for more expansive use of real-world data from traditionally underrepresented populations. We can continue to prioritize de-identification and patient privacy as we grow our data-sharing networks to encourage contribution and participation. We can proactively connect with representatives from underserved groups to provide education about clinical trials. We can keep working across the healthcare enterprise to refine our research approaches, expand access to breakthrough therapies, and support patients throughout their healthcare journey.

This is a moral imperative. For the sake of our neighbors, friends, families, and colleagues, we cannot afford not to be inclusive when it comes to clinical trials for cancer and the real-world evaluation of new protocols. The choices we make now will directly impact the lives of millions as we look to a future where sharing patient data with researchers is empowering and rewarding for all.

Comments Off on Readers Write: Sharing Diverse Patient Data to Support Clinical Trials: Can We Afford Not To?

Text Ads


RECENT COMMENTS

  1. Going to ask again about HealWell - they are on an acquisition tear and seem to be very AI-focused. Has…

  2. If HIMSS incorporated as a for profit it would have had to register with a Secretary of State in Illinois.…

  3. I read about that last week and it was really one of the most evil-on-a-personal-level things I've seen in a…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.